Literature DB >> 10843158

Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism.

G Barletta1, M L De Feo, R Del Bene, C Lazzeri, S Vecchiarino, G La Villa, M L Brandi, F Franchi.   

Abstract

The aim of the study was to evaluate: 1) the cardiovascular function and the autonomic drive to the heart in patients affected by primary hyperparathyroidism (pHPT) with no evidence of renal and cardiovascular complications; 2) the cardiovascular effects of acute administration of PTH in normal subjects. In 14 patients affected by mild asymptomatic pHPT echocardiographic assessment of cardiovascular function and of the mechanic properties of the brachial and carotid artery, heart rate variability and the dispersion of QT interval were performed before and 6 months after successful surgery. Twenty age- and sex-matched healthy subjects were included in the study. Five healthy volunteers underwent a single blind, placebo-controlled, random order, cross-over study with infusion of PTH (hPTH 1-34, 200 U in saline over 5 min) or placebo. Echocardiographic assessment of cardiovascular function, heart rate variability, and QT interval were performed between 20 and 25 min after the start of the infusion and repeated after 15 min of tilting at 60 degrees. In pHPT patients the echocardiographic parameters were normal; left ventricular isovolumetric relaxation time was always in the normal range, but significantly shorter than in control subjects, suggesting an increased sympathetic stimulation. Arterial diameters and thickness, blood pressure, and QT interval were not significantly different with respect to normal subjects and were unchanged 6 months after surgery. pHPT patients lacked the circadian rhythm of the low frequency to high frequency ratio, suggesting an increased sympathetic drive to the heart at nighttime. In normal subjects there were no significant differences in basal echocardiographic measurements during PTH infusion with respect to placebo and in the hemodynamic response to tilt. These results suggest that cardiovascular function is substantially normal in normotensive pHPT patients with mild hypercalcemia. A modulation of the adrenergic control of circulation seems to be associated with hypercalcemia and/or chronic PTH excess, but its biological relevance needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843158     DOI: 10.1210/jcem.85.5.6514

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  D S Rao
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes.

Authors:  Soumya Patnaik; Yu Kuang Lai
Journal:  BMJ Case Rep       Date:  2015-10-21

3.  The Harder the Heart, the Harder It Breaks: A Case of Complete Atrioventricular Block Secondary to Tertiary Hyperparathyroidism.

Authors:  Ramanakumar Anam; Mauricio Tellez; Matthew Lozier; Ameen Waheed; Jose E Collado
Journal:  Cureus       Date:  2021-02-11

4.  Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy?

Authors:  Alper Kepez; Mehmet Yasar; Murat Sunbul; Cigdem Ileri; Oguzhan Deyneli; Bulent Mutlu; Osman Yesildag; Yelda Basaran
Journal:  Wien Klin Wochenschr       Date:  2017-03-17       Impact factor: 1.704

5.  Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism.

Authors:  B Aktas Yılmaz; A Akyel; E Kan; U Ercin; Y Tavil; A Bilgihan; N Cakır; M Arslan; F Balos Toruner
Journal:  J Endocrinol Invest       Date:  2013-05-10       Impact factor: 4.256

6.  Emerging data on cardiovascular risk in primary hyperparathyroidism.

Authors:  Jessica Pepe; Sara Piemonte; Cristiana Cipriani; Mirella Cilli; Salvatore Minisola
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

7.  Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.

Authors:  A J van Ballegooijen; M Visser; M F Cotch; A E Arai; M Garcia; T B Harris; L J Launer; G Eiríksdóttir; V Gudnason; I A Brouwer
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

8.  Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy.

Authors:  P Farahnak; M Ring; K Caidahl; L-O Farnebo; M J Eriksson; I-L Nilsson
Journal:  Eur J Endocrinol       Date:  2010-06-18       Impact factor: 6.664

9.  Effect of hypoxia on parathyroid hormone in lactating and neonatal rats: interaction with halothane.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

10.  Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients.

Authors:  Alper Kepez; Ayla Harmanci; Tuncay Hazirolan; Mehlika Isildak; Ugur Kocabas; Ahmet Ates; Orcun Ciftci; Lale Tokgozoglu; Alper Gürlek
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-11       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.